Value sales of analgesics is expected to remain unchanged in 2021. While there was a huge surge in analgesics sales in 2020, as it was used to alleviate symptoms of COVID-19, now that fears around of the virus have abated somewhat, there is expected to be less demand for analgesics. In addition, with many COVID-19 restrictions still in place in 2021, such as social distancing, there is fewer common colds and flus and as a result, less need for analgesics. Lastly, consumers are still using the ex...

Euromonitor International’s Analgesics in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.